PAI
ProQuest Associates IV Portfolio holdings
AUM
$53M
This Quarter Return
-14.37%
1 Year Return
+3.35%
3 Year Return
+116.54%
5 Year Return
–
10 Year Return
–
AUM
$53M
AUM Growth
+$53M
(-19%)
Cap. Flow
-$513K
Cap. Flow
% of AUM
-0.97%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
$513K |
Sector Composition
| 1 | Healthcare | 88.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
UroGen Pharma
URGN
$878M
| $37.3M | 70.39% |
789,297
| – | – |
|
2
Mersana Therapeutics
MRSN
$36.2M
| $9.56M | 18.05% |
955,709
| – | – |
|
|
IMDZ
3
DELISTED
Immune Design Corp.
IMDZ
| $4.27M | 8.06% |
1,236,394
| – | – |
|
|
AGRX
4
DELISTED
Agile Therapeutics, Inc
AGRX
| $1.86M | 3.5% |
5,062,363
| – | – |
|
|
EGRX
5
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| – | – |
-6,777
| Closed | -$513K |
|